3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Other hematologic neoplasm
1
Other
1
Gastrointestinal
1
Conditions
Neutropenia
1
Mucositis
1
Infections
1
Hyperphagia
1
Colitis
1
Interventions
Radiotherapy
5
Surveys and Questionnaires
4
Cisplatin
4
angiotensin I (1-7)
3
alvimopan
3
Radiation
3
Injections
3
Water
2
Vitamin D
2
Tirzepatide
2
RRx-001
2
Mouthwashes
2
Metformin
2
Interleukin 1 Receptor Antagonist Protein
2
High-Intensity Focused Ultrasound Ablation
2
Drug Therapy
2
Dexmedetomidine
2
Dexamethasone
2
Calcium Dobesilate
2
Amifostine
2
Acetylcysteine
2
tempol
1
peppermint oil
1
pegfilgrastim
1
naloxegol
1
methylnaltrexone
1
methyl N-acetylsibirosaminide
1
linaclotide
1
licogliflozin
1
kang-lai-te
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
fish oil triglycerides
×
Other
×
Clear all
NCT00533078
2015-07-23
LUNCH1
Insel Gruppe AG, University Hospital Bern
Phase 2
Completed
14 enrolled